Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ilant Health vs TeleDocs360

Ilant Health
Graded #407

Higher grade

vs+1.5999999999999943
TeleDocs360
Graded #444

Lower grade

The verdict

Ilant Health takes it — 56.8/100 to 55.2/100, but only just.

Ilant Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ilant Health is a value-based obesity and cardiometabolic care company distributed through employers and health plans rather than direct cash-pay. TeleDocs360 is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIlant Health +18
45
27
Dose & formulationTeleDocs360 +35
40
75
Clinical oversightTeleDocs360 +1
83
84
Labs & monitoringIlant Health +9
61
52
FulfillmentIlant Health +2
62
60
Contract termsIlant Health +35
55
20
Ilant Health · left barTeleDocs360 · right bar

The numbers

MetricIlant HealthTeleDocs360
WeighScore56.8/10055.2/100
GradeCC
Scorecard rank#407#444
SemaglutideNot disclosed$399/mo (compounded)
TirzepatideNot disclosed$399/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Ilant Health

Graded #407 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1
TeleDocs360

Graded #444 · C

Strengths

  • Transparent $399/month base pricing for standard dosing
  • Multiple GLP-1 options including injectable and oral semaglutide
  • Cash-pay model with HSA/FSA card acceptance
  • Fast online intake and 24-hour prescription approval
  • Cancel anytime between shipments

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • No individual provider credentials or board certifications shown
  • Higher doses increase cost

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard